以伯纳氏杆菌为模式生物抗细胞内病原体的纳米疫苗

{"title":"以伯纳氏杆菌为模式生物抗细胞内病原体的纳米疫苗","authors":"E. J. V. Schaik, A. E. Gregory, G. Audette, J. Samuel","doi":"10.1201/B22372-16","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":142266,"journal":{"name":"Immune Aspects of Biopharmaceuticals and Nanomedicines","volume":"165 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Nanovaccines against Intracellular Pathogens Using Coxiella burnetii as a Model Organism\",\"authors\":\"E. J. V. Schaik, A. E. Gregory, G. Audette, J. Samuel\",\"doi\":\"10.1201/B22372-16\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":142266,\"journal\":{\"name\":\"Immune Aspects of Biopharmaceuticals and Nanomedicines\",\"volume\":\"165 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immune Aspects of Biopharmaceuticals and Nanomedicines\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1201/B22372-16\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immune Aspects of Biopharmaceuticals and Nanomedicines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1201/B22372-16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}